These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22458771)

  • 1. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.
    Grönhagen CM; Fored CM; Linder M; Granath F; Nyberg F
    Br J Dermatol; 2012 Aug; 167(2):296-305. PubMed ID: 22458771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced cutaneous lupus erythematosus: 88 new cases.
    Laurinaviciene R; Sandholdt LH; Bygum A
    Eur J Dermatol; 2017 Feb; 27(1):28-33. PubMed ID: 27799135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus.
    Haugaard JH; Kofoed K; Gislason G; Dreyer L; Egeberg A
    JAMA Dermatol; 2020 Nov; 156(11):1199-1207. PubMed ID: 32876672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of drug-induced subacute cutaneous lupus erythematosus.
    Lowe GC; Henderson CL; Grau RH; Hansen CB; Sontheimer RD
    Br J Dermatol; 2011 Mar; 164(3):465-72. PubMed ID: 21039412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Bonsmann G; Schiller M; Luger TA; Ständer S
    J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [When drugs induce cutaneous lupus erythematosus].
    Skovmøller KB; Bygum A
    Ugeskr Laeger; 2018 Oct; 180(41):. PubMed ID: 30327081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of cancer among 3663 patients with cutaneous lupus erythematosus: a Swedish nationwide cohort study.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2012 May; 166(5):1053-9. PubMed ID: 22175767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue eosinophilia: not an indicator of drug-induced subacute cutaneous lupus erythematosus.
    Hillesheim PB; Bahrami S; Jeffy BG; Callen JP
    Arch Dermatol; 2012 Feb; 148(2):190-3. PubMed ID: 22004879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update in drug-induced subacute cutaneous lupus erythematosus.
    Michaelis TC; Sontheimer RD; Lowe GC
    Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
    Cohen MR; Crosby D
    J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K; Booken N; Goerdt S; Goebeler M
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM; John LH; Buckley DA
    Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced subacute cutaneous lupus erythematosus.
    Callen JP
    Lupus; 2010 Aug; 19(9):1107-11. PubMed ID: 20693204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
    Popovic K; Nyberg F; Wahren-Herlenius M; Nyberg F
    Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.